UK markets close in 4 hours 55 minutes
  • FTSE 100

    6,962.21
    +22.63 (+0.33%)
     
  • FTSE 250

    22,420.85
    +65.40 (+0.29%)
     
  • AIM

    1,247.01
    +3.10 (+0.25%)
     
  • GBP/EUR

    1.1516
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.3782
    +0.0001 (+0.01%)
     
  • BTC-GBP

    45,361.25
    -789.91 (-1.71%)
     
  • CMC Crypto 200

    1,364.68
    -11.10 (-0.81%)
     
  • S&P 500

    4,124.66
    -16.93 (-0.41%)
     
  • DOW

    33,730.89
    +53.62 (+0.16%)
     
  • CRUDE OIL

    62.69
    -0.46 (-0.73%)
     
  • GOLD FUTURES

    1,747.60
    +11.30 (+0.65%)
     
  • NIKKEI 225

    29,642.69
    +21.70 (+0.07%)
     
  • HANG SENG

    28,793.14
    -107.69 (-0.37%)
     
  • DAX

    15,245.64
    +36.49 (+0.24%)
     
  • CAC 40

    6,222.75
    +14.17 (+0.23%)
     

The Global Anti-obesity Drugs Market is expected to grow by $ 454.51 mn during 2021-2025 decelerate at a CAGR of 5% during the forecast period

ReportLinker
·3-min read

Global Anti-obesity Drugs Market 2021-2025 The analyst has been monitoring the anti-obesity drugs market and it is poised to grow by $ 454. 51 mn during 2021-2025 decelerate at a CAGR of 5% during the forecast period.

New York, March 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Anti-obesity Drugs Market 2021-2025" - https://www.reportlinker.com/p05638946/?utm_source=GNW
Our reports on anti-obesity drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the limited number of approved drugs and use of bariatric surgery limited for morbid obesity. In addition, limited number of approved drugs is anticipated to boost the growth of the market as well.
The anti-obesity drugs market analysis includes type segment and geographical landscapes.

The anti-obesity drugs market is segmented as below:
By Type
• class III anti-obesity drugs
• class II anti-obesity drugs
• class I anti-obesity drugs

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the growing obese population as one of the prime reasons driving the anti-obesity drugs market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anti-obesity drugs market covers the following areas:
• Anti-obesity drugs market sizing
• Anti-obesity drugs market forecast
• Anti-obesity drugs market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-obesity drugs market vendors that include Bausch Health Companies Inc., Currax Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd., Gelesis Inc., GlaxoSmithKline Plc, Novo Nordisk AS, RECORDATI S.p.A., Rhythm Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., and VIVUS Inc.. Also, the anti-obesity drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Read the full report: https://www.reportlinker.com/p05638946/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001